Depression and employment status in primary and tertiary care settings

Canadian Journal of Psychiatry

Volumn 60, Issue 1, 2015, Pages 14-22

  Rizvi, Sakina J ^a   Cyriac, Anna ^a   Grima, Etienne ^b   Tan, Mary ^a   Lin, Peter ^a   Gallaugher, Laura Ashley ^a   McIntyre, Roger S ^a,c   Kennedy, Sidney H ^a,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b CardioComm Solutions Canadian Heart Research Centre   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Absenteeism; Canada; Depression; Disability; Major depressive disorder; Prevalence; Unemployment; Workplace

Indexed keywords

BENZODIAZEPINE;

ADULT; ANHEDONIA; ANXIETY DISORDER; ARTICLE; CANADA; CLINICAL FEATURE; COMORBIDITY; DISABILITY; DISEASE SEVERITY; EMPLOYMENT STATUS; FEMALE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PREDICTIVE VALUE; PRIMARY HEALTH CARE; TERTIARY HEALTH CARE; UNEMPLOYMENT; AGED; COST OF ILLNESS; CROSS-SECTIONAL STUDY; DEPRESSIVE DISORDER, MAJOR; ECONOMICS; MIDDLE AGED; NEEDS ASSESSMENT; PREVALENCE; PSYCHOLOGY; RISK FACTOR; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ANHEDONIA; BRITISH COLUMBIA; COMORBIDITY; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEEDS ASSESSMENT; PREVALENCE; PRIMARY HEALTH CARE; QUEBEC; RISK FACTORS; SOCIOECONOMIC FACTORS; TERTIARY HEALTHCARE; UNEMPLOYMENT;

EID: 84920997230     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371506000105     Document Type: Article

References (43)

1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349(9063):1436-1442.
2. Patten SB, Kennedy SH, Lam RW, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management. J Affect Disord. 2009;117(Suppl 1):S5-S14.
3. Dewa CS, Lesage A, Goering P, et al. Nature and prevalence of mental illness in the workplace. Healthc Pap. 2004;5(2):12-25.
4. Munce SE, Stansfeld SA, Blackmore ER, et al. The role of depression and chronic pain conditions in absenteeism: results from a national epidemiologic survey. J Occup Environ Med. 2007;49(11):1206-1211.
5. Goetzel RZ, Hawkins K, Ozminkowski RJ, et al. The health and productivity cost burden of the "top 10 physical and mental health conditions affecting six large US employers in 1999. J Occup Environ Med. 2003;45(1):5-14.
6. Kessler RC, Barber C, Birnbaum HG, et al. Depression in the workplace: effects on short-term disability. Health Aff (Millwood). 1999;18(5):163-171.
7. Kessler RC. The costs of depression. Psychiatr Clin North Am. 2012;35(1):1-14.
8. Stephens T, Joubert N. The economic burden of mental health problems in Canada. Chronic Dis Can. 2001;22(1):18-23.
9. Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry. 2003;64(12):1465-1475.
10. Dewa CS, Chau N, Dermer S. Examining the comparative incidence and costs of physical and mental health-related disabilities in an employed population. J Occup Environ Med. 2010;52(7):758-762.
11. Birnbaum HG, Kessler RC, Kelley D, et al. Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance. Depress Anxiety. 2010;27(1):78-89.
12. McIntyre RS, Wilkins K, Gilmour H, et al. The effect of bipolar I disorder and major depressive disorder on workforce function. Chronic Dis Can. 2008;28(3):84-91.
13. Dewa CS, Goering P, Lin E, et al. Depression-related short-term disability in an employed population. J Occup Environ Med. 2002;44(7):628-633.
14. Blackmore ER, Stansfeld SA, Weller I, et al. Major depressive episodes and work stress: results from a national population survey. Am J Public Health. 2007;97(11):2088-2093.
15. Kessler RC, Akiskal HS, Ames M, et al. Prevalence and effects of mood disorders on work performance in a nationally representative sample of US workers. Am J Psychiatry. 2006;163(9):1561-1568.
16. Lerner D, Adler DA, Chang, H, et al. Unemployment, job retention, and productivity loss among employees with depression. Psychiatr Serv. 2004;55(12):1371-1378.
17. Dooley D, Fielding J, Levi L. Health and unemployment. Annu Rev Public Health. 1996;17:449-465.
18. Jefferis BJ, Nazareth I, Marston L, et al. Associations between unemployment and major depressive disorder: evidence from an international, prospective study (the predict cohort). Soc Sci Med. 2011;73(11):1627-1634.
19. Rizvi SJ, Grima E, Tan M, et ak. Treatment-resistant depression in primary care across Canada. Can J Psychiatry. 2014;59(7):349-357.
20. McIntyre RS, Kennedy SH, Soczynska JK, et al. Attention-deficit/ hyperactivity disorder in adults with bipolar disorder or major depressive disorder: results from the international mood disorders collaborative project. Prim Care Companion J Clin Psychiatry. 2010;12(3). pii: PCC.09m00861.
21. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22-33.
22. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
23. Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389.
24. Lehrer PM, Woolfolk R.L. Self-report assessment of anxiety: somatic, cognitive, and behavioral modalities. J Behav Assess. 1982;4:167-177.
25. Endicott J, Nee J, Harrison W, et al. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull. 1993;29:321-326.
26. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol. 1996;11(Suppl 3):89-95.
27. Endicott J, Nee J. Endicott Work Productivity Scale (EWPS): a new measure to assess treatment effects. Psychopharmacol Bull. 1997;33(1):13-16.
28. Akyeampong EB. Canada's unemployment mosaic, 2000 to 2006. Perspectives on Labour and Income. 2007;8:5-12.
29. Lerner D, Henke RM. What does research tell us about depression, job performance, and work productivity? J Occup Environ Med. 2008;50(4):401-410.
30. McMakin DL, Olino TM, Porta G, et al. Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression. J Am Acad Child Adolesc Psychiatry. 2012;51(4):404-411.
31. Uher R, Perlis RH, Henigsberg N, et al. Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychol Med. 2012;42(5):967-980.
32. Gualtieri CT, Morgan DW. The frequency of cognitive impairment in patients with anxiety, depression, and bipolar disorder: an unaccounted source of variance in clinical trials. J Clin Psychiatry. 2008;69(7):1122-1130.
33. Reppermund S, Ising M, Lucae S, et al. Cognitive impairment in unipolar depression is persistent and non-specific: further evidence for the final common pathway disorder hypothesis. Psychol Med. 2009;39(4):603-614.
34. Nebes RD, Butters MA, Mulsant BH, et al. Decreased working memory and processing speed mediate cognitive impairment in geriatric depression. Psychol Med. 2000;30(3):679-691.
35. Millan MJ, Agid Y, Brüne M, et al. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov. 2012;11(2):141-168.
36. McIntyre RS, Cha DS, Soczynska JK, et al. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress Anxiety. 2013;30(6):515-527.
37. Dawson J, Boyle J, Stanley N, et al. Benzodiazepineinduced reduction in activity mirrors decrements in cognitive and psychomotor performance. Hum Psychopharmacol. 2008;23(7):605-613.
38. Tannenbaum C, Paquette A, Hilmer S, et al. A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging. 2012;29(8):639-658.
39. McIntyre RS, Liauw S, Taylor VH. Depression in the workforce: the intermediary effect of medical comorbidity. J Affect Disord. 2011;128(Suppl 1):S29-S36.
40. McIntyre RS, Cha DS, Jerrell JM, et al. Obesity and mental illness: implications for cognitive functioning. Adv Ther. 2013;30(6):577-588.
41. Wallin K, Solomon A, Kåreholt I, et al. Midlife rheumatoid arthritis increases the risk of cognitive impairment two decades later: a population-based study. J Alzheimers Dis. 2012;31(3):669-676.
42. Rost K, Fortney J, Coyne J. The relationship of depression treatment quality indicators to employee absenteeism. Ment Health Serv Res. 2005;7(3):161-169.
43. Egede LE. Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. Gen Hosp Psychiatry. 2007;29(5):409-416.